Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a press release issued by Aayush Wellness Limited ('the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aayush Wellness Limited's Board of Directors, at a meeting held on June 9, 2025, approved the formation of a wholly owned subsidiary in Singapore. The subsidiary will be set up with an initial capital investment of SGD 10,000. It will serve as a launchpad for the company's nutraceutical and healthcare products across Southeast Asian markets including Malaysia, Indonesia, Thailand, and Vietnam. The company also plans to establish a regional R&D and innovation hub and forge e-commerce distribution partnerships in the ASEAN region. The Southeast Asian nutraceutical market is projected to reach USD 15.1 billion by 2028, growing at 7.5% CAGR, with Singapore's nutraceutical sector alone valued at over USD 1.3 billion.
This is a small initial investment but signals the company's intent to expand internationally and diversify beyond the Indian market. Short-term impact on stock price is likely limited given the modest capital commitment, but it opens a new growth corridor for shareholders if the Southeast Asia expansion gains traction.